Simulation modeling study reports reduced breast cancer mortality from screening and adjuvant therapy in US women, highlighting variation across molecular subtypes.
In this simulation modeling study that projected trends in breast cancer mortality rates among US women, decreases in overall breast cancer mortality from 2000 to 2012 were associated with advances in screening and in adjuvant therapy, although the associations varied by breast cancer molecular subtype.
No takes yet. Share an insight, caveat, or question.
Plevritis et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: